ProfileGDS4718 / 227050_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 47% 47% 51% 48% 47% 44% 54% 52% 54% 49% 44% 47% 49% 48% 50% 50% 47% 45% 45% 56% 50% 51% 51% 48% 48% 44% 45% 49% 46% 49% 44% 50% 48% 44% 39% 51% 55% 49% 51% 51% 50% 46% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5756251
GSM549102patient 115, normal, homogenized [OPG study]5.3835147
GSM549104patient 119, normal, homogenized [OPG study]5.3375547
GSM549108patient 138, normal, homogenized [OPG study]5.6282151
GSM549119patient 077, normal, homogenized [OPG study]5.3923648
GSM549133patient 032, cancer, homogenized [OPG study]5.2762647
GSM549139patient 042, cancer, homogenized [OPG study]5.1797644
GSM549099patient 107, normal, homogenized [OPG study]5.7187354
GSM549109patient 139, normal, homogenized [OPG study]5.6747652
GSM549110patient 046, normal, homogenized [OPG study]5.7160254
GSM549114patient 063, normal, homogenized [OPG study]5.4363649
GSM549122patient 082, normal, homogenized [OPG study]5.2120144
GSM549134patient 033, cancer, homogenized [OPG study]5.3044447
GSM549136patient 036, cancer, homogenized [OPG study]5.3876149
GSM549140patient 044, cancer, homogenized [OPG study]5.3421748
GSM549111patient 047, normal, homogenized [OPG study]5.4708950
GSM549113patient 057, normal, homogenized [OPG study]5.475350
GSM549132patient 031, cancer, homogenized [OPG study]5.3171347
GSM549137patient 038, cancer, homogenized [OPG study]5.2130345
GSM549142patient 047, cancer, homogenized [OPG study]5.3635745
GSM549100patient 110, normal, homogenized [OPG study]5.848756
GSM549107patient 135, normal, homogenized [OPG study]5.4872450
GSM549115patient 068, normal, homogenized [OPG study]5.5011551
GSM549116patient 072, normal, homogenized [OPG study]5.5534751
GSM549120patient 078, normal, homogenized [OPG study]5.4280348
GSM549131patient 030, cancer, homogenized [OPG study]5.3403948
GSM549118patient 074, normal, homogenized [OPG study]5.1828944
GSM549129patient 027, cancer, homogenized [OPG study]5.2377845
GSM549123patient 088, normal, homogenized [OPG study]5.4171549
GSM549124patient 006, cancer, homogenized [OPG study]5.3089746
GSM549126patient 015, cancer, homogenized [OPG study]5.4217649
GSM549128patient 025, cancer, homogenized [OPG study]5.1556244
GSM549103patient 117, normal, homogenized [OPG study]5.5469250
GSM549117patient 073, normal, homogenized [OPG study]5.3441348
GSM549138patient 041, cancer, homogenized [OPG study]5.1581544
GSM549141patient 045, cancer, homogenized [OPG study]4.8973239
GSM549130patient 028, cancer, homogenized [OPG study]5.5551251
GSM549101patient 111, normal, homogenized [OPG study]5.863155
GSM549105patient 128, normal, homogenized [OPG study]5.4877449
GSM549106patient 134, normal, homogenized [OPG study]5.5289351
GSM549112patient 048, normal, homogenized [OPG study]5.5915151
GSM549125patient 011, cancer, homogenized [OPG study]5.5191650
GSM549127patient 024, cancer, homogenized [OPG study]5.3034746
GSM549135patient 035, cancer, homogenized [OPG study]5.3062247